Site-specific topoisomerase I-mediated DNA cleavage induced by nogalamycin

A potential role of ligand-induced DNA bending at a distal site

S. P. Sim, D. S. Pilch, Leroy-Fong Liu

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Many DNA binding ligands (e.g., nogalamycin, actinomycin D, terbenzimidazoles, indolocarbazoles, nitidine, and coralyne) and various types of DNA lesions (e.g., UV dimers, DNA mismatches, and abasic sites) are known to stimulate topoisomerase I-mediated DNA cleavage. However, the mechanism(s) by which these covalent and noncovalent DNA interactions stimulate topoisomerase I-mediated DNA cleavage remains unclear. Using nogalamycin as a model, we have studied the mechanism of ligand-induced topoisomerase I-mediated DNA cleavage. We show by both mutational and DNA footprinting analyses that the binding of nogalamycin to an upstream site (from position -6 to -3) can induce highly specific topoisomerase I-mediated DNA cleavage. Substitution of this nogalamycin binding site with a DNA bending sequence (A 5) stimulated topoisomerase I-mediated DNA at the same site in the absence of nogalamycin. Replacement of the As sequence with a disrupted DNA bending sequence (A 2-TA 2) significantly reduced the level of topoisomerase I-mediated DNA cleavage. These results, together with the known DNA bending property of nogalamycin, suggest that the nogalamycin-DNA complex may provide a DNA structural bend to stimulate topoisomerase I-mediated DNA cleavage.

Original languageEnglish
Pages (from-to)9928-9934
Number of pages7
JournalBiochemistry
Volume39
Issue number32
DOIs
Publication statusPublished - Aug 15 2000
Externally publishedYes

Fingerprint

Nogalamycin
Type I DNA Topoisomerase
DNA Cleavage
Ligands
DNA
coralyne
DNA Mutational Analysis
DNA Footprinting
Dactinomycin
varespladib methyl
Binding Sites

ASJC Scopus subject areas

  • Biochemistry

Cite this

Site-specific topoisomerase I-mediated DNA cleavage induced by nogalamycin : A potential role of ligand-induced DNA bending at a distal site. / Sim, S. P.; Pilch, D. S.; Liu, Leroy-Fong.

In: Biochemistry, Vol. 39, No. 32, 15.08.2000, p. 9928-9934.

Research output: Contribution to journalArticle

@article{d4b058a159e048c4b439ae855230cb17,
title = "Site-specific topoisomerase I-mediated DNA cleavage induced by nogalamycin: A potential role of ligand-induced DNA bending at a distal site",
abstract = "Many DNA binding ligands (e.g., nogalamycin, actinomycin D, terbenzimidazoles, indolocarbazoles, nitidine, and coralyne) and various types of DNA lesions (e.g., UV dimers, DNA mismatches, and abasic sites) are known to stimulate topoisomerase I-mediated DNA cleavage. However, the mechanism(s) by which these covalent and noncovalent DNA interactions stimulate topoisomerase I-mediated DNA cleavage remains unclear. Using nogalamycin as a model, we have studied the mechanism of ligand-induced topoisomerase I-mediated DNA cleavage. We show by both mutational and DNA footprinting analyses that the binding of nogalamycin to an upstream site (from position -6 to -3) can induce highly specific topoisomerase I-mediated DNA cleavage. Substitution of this nogalamycin binding site with a DNA bending sequence (A 5) stimulated topoisomerase I-mediated DNA at the same site in the absence of nogalamycin. Replacement of the As sequence with a disrupted DNA bending sequence (A 2-TA 2) significantly reduced the level of topoisomerase I-mediated DNA cleavage. These results, together with the known DNA bending property of nogalamycin, suggest that the nogalamycin-DNA complex may provide a DNA structural bend to stimulate topoisomerase I-mediated DNA cleavage.",
author = "Sim, {S. P.} and Pilch, {D. S.} and Leroy-Fong Liu",
year = "2000",
month = "8",
day = "15",
doi = "10.1021/bi000906h",
language = "English",
volume = "39",
pages = "9928--9934",
journal = "Biochemistry",
issn = "0006-2960",
publisher = "American Chemical Society",
number = "32",

}

TY - JOUR

T1 - Site-specific topoisomerase I-mediated DNA cleavage induced by nogalamycin

T2 - A potential role of ligand-induced DNA bending at a distal site

AU - Sim, S. P.

AU - Pilch, D. S.

AU - Liu, Leroy-Fong

PY - 2000/8/15

Y1 - 2000/8/15

N2 - Many DNA binding ligands (e.g., nogalamycin, actinomycin D, terbenzimidazoles, indolocarbazoles, nitidine, and coralyne) and various types of DNA lesions (e.g., UV dimers, DNA mismatches, and abasic sites) are known to stimulate topoisomerase I-mediated DNA cleavage. However, the mechanism(s) by which these covalent and noncovalent DNA interactions stimulate topoisomerase I-mediated DNA cleavage remains unclear. Using nogalamycin as a model, we have studied the mechanism of ligand-induced topoisomerase I-mediated DNA cleavage. We show by both mutational and DNA footprinting analyses that the binding of nogalamycin to an upstream site (from position -6 to -3) can induce highly specific topoisomerase I-mediated DNA cleavage. Substitution of this nogalamycin binding site with a DNA bending sequence (A 5) stimulated topoisomerase I-mediated DNA at the same site in the absence of nogalamycin. Replacement of the As sequence with a disrupted DNA bending sequence (A 2-TA 2) significantly reduced the level of topoisomerase I-mediated DNA cleavage. These results, together with the known DNA bending property of nogalamycin, suggest that the nogalamycin-DNA complex may provide a DNA structural bend to stimulate topoisomerase I-mediated DNA cleavage.

AB - Many DNA binding ligands (e.g., nogalamycin, actinomycin D, terbenzimidazoles, indolocarbazoles, nitidine, and coralyne) and various types of DNA lesions (e.g., UV dimers, DNA mismatches, and abasic sites) are known to stimulate topoisomerase I-mediated DNA cleavage. However, the mechanism(s) by which these covalent and noncovalent DNA interactions stimulate topoisomerase I-mediated DNA cleavage remains unclear. Using nogalamycin as a model, we have studied the mechanism of ligand-induced topoisomerase I-mediated DNA cleavage. We show by both mutational and DNA footprinting analyses that the binding of nogalamycin to an upstream site (from position -6 to -3) can induce highly specific topoisomerase I-mediated DNA cleavage. Substitution of this nogalamycin binding site with a DNA bending sequence (A 5) stimulated topoisomerase I-mediated DNA at the same site in the absence of nogalamycin. Replacement of the As sequence with a disrupted DNA bending sequence (A 2-TA 2) significantly reduced the level of topoisomerase I-mediated DNA cleavage. These results, together with the known DNA bending property of nogalamycin, suggest that the nogalamycin-DNA complex may provide a DNA structural bend to stimulate topoisomerase I-mediated DNA cleavage.

UR - http://www.scopus.com/inward/record.url?scp=0034663907&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034663907&partnerID=8YFLogxK

U2 - 10.1021/bi000906h

DO - 10.1021/bi000906h

M3 - Article

VL - 39

SP - 9928

EP - 9934

JO - Biochemistry

JF - Biochemistry

SN - 0006-2960

IS - 32

ER -